Free Trial
OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

MariMed logo
$0.11 +0.00 (+4.55%)
As of 04/25/2025 03:58 PM Eastern

About MariMed Stock (OTCMKTS:MRMD)

Key Stats

Today's Range
$0.10
$0.12
50-Day Range
$0.08
$0.14
52-Week Range
$0.07
$0.34
Volume
481,784 shs
Average Volume
399,765 shs
Market Capitalization
$41.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

MRMD Stock News Headlines

MariMed Announces First Quarter 2025 Earnings Date
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Marimed launches Nature’s Heritage Flower in Illinois
See More Headlines

MRMD Stock Analysis - Frequently Asked Questions

MariMed's stock was trading at $0.1158 at the start of the year. Since then, MRMD stock has decreased by 6.7% and is now trading at $0.1080.
View the best growth stocks for 2025 here
.

MariMed Inc. (OTCMKTS:MRMD) released its quarterly earnings results on Wednesday, March, 5th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). The company earned $39 million during the quarter, compared to the consensus estimate of $42 million. MariMed had a negative net margin of 10.97% and a negative trailing twelve-month return on equity of 2.75%.
Read the conference call transcript
.

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MariMed investors own include Canopy Growth (CGC), Innovative Industrial Properties (IIPR), NVIDIA (NVDA), Curaleaf (CURLF), Aurora Cannabis (ACB), Meta Platforms (META) and Tilray (TLRY).

Company Calendar

Last Earnings
3/05/2025
Today
4/25/2025
Next Earnings (Estimated)
5/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MRMD
Fax
N/A
Employees
260
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-16,030,000.00
Pretax Margin
-5.28%

Debt

Sales & Book Value

Annual Sales
$148.60 million
Cash Flow
$0.02 per share
Price / Cash Flow
5.59
Book Value
$0.19 per share
Price / Book
0.57

Miscellaneous

Free Float
301,649,000
Market Cap
$41.20 million
Optionable
Not Optionable
Beta
2.75
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (OTCMKTS:MRMD) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners